Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer?
Abstract Breast cancer (BrCa) is a complex and heterogeneous disease with diverse molecular subtypes, leading to varied clinical outcomes and posing significant treatment challenges. The increasing global burden of BrCa, particularly in low- and middle-income countries, underscores the urgent need f...
Saved in:
Main Authors: | Tryambak Pratap Srivastava, Ruby Dhar, Subhradip Karmakar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12958-024-01338-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
by: Caihong Li, et al.
Published: (2025-02-01) -
The correlation between the expression of androgen receptor splice variant-7 (AR-V7) protein with the time of occurrence of castration-resistant prostate cancer and overall survival in prostate cancer in Indonesian population
by: Indrawarman Soerohardjo, et al.
Published: (2025-02-01) -
Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication
by: Jessica K. Heatlie, et al.
Published: (2024-12-01) -
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression
by: Jasper Van Goubergen, et al.
Published: (2025-02-01) -
Community pharmacy’s role in dispensing androgens and supporting harm reduction amid current policy dilemmas
by: Timothy Piatkowski, et al.
Published: (2025-01-01)